Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
They’re the 2019 recipients of amfAR’s Mathilde Krim Fellowship in Basic Biomedical Research.
Of particular concern is the considerable proportion of HIV-positive women not getting viral load and CD4 tests often enough.
Expanded access study confirms the long-acting monoclonal antibody works well in people with extensive prior treatment.
Any HIV cure on the horizon will have to tackle macrophage immune cells as well as CD4 T Cells, a study indicates.
According to a systematic review and meta-analysis of dozens of studies, people with HIV have high rates of cardiac dysfunction
HIV-positive people with a higher viral load over a longer period appear more likely to develop hepatocellular carcinoma.
A study finds that CD4 cells decline after people with HIV contract hepatitis C.
A review of randomized controlled trials found that the main apparent benefit of such testing occurred among those with virologic failure.
This holds true regardless of how long they’ve had HIV or whether they’re on antiretrovirals.
A lesson that adherence to HIV medication is a reality, even for long-term survivors
Those who begin antiretrovirals with a higher CD4 count and CD4 to CD8 ratio are more likely to experience immune recovery.
Just ask Nicholaus Johnson, a former “junkie” with AIDS who is now a sober college student helping the HIV community.
People who have a low CD4 count, have cirrhosis and take certain hep C drug regimens are less likely to be cured.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.